Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Steven G. DuBois"'
Publikováno v:
Pediatric Drugs.
Autor:
Lauriane Lemelle, Tim Flaadt, Brice Fresneau, Antoine Moya-Plana, Beate Timmermann, Jelena Roganovic, Andrea Ferrari, Giulia Fichera, Ulrich M. Lauer, Tal Ben-Ami, Dominik T. Schneider, Christian Vokuhl, Stephanie Bolle, Elisabeth Fox, Steven G. DuBois, Carlos Rodriguez-Galindo, Gianni Bisogno, Aurore Surun, Ines B. Brecht, Daniel Orbach
Nuclear protein of the testis (NUT) carcinoma (NC) is a rare and highly aggressive tumor mainly occurring in adolescents and young adults, defined by the presence of a somatic NUTM1 rearrangement. The aim is to establish internationally harmonized co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f739d4dfe4a6980eab6f5b275a32d0
https://www.ncbi.nlm.nih.gov/pubmed/36219702
https://www.ncbi.nlm.nih.gov/pubmed/36219702
Autor:
Jaclynne H, Nader, Florence, Bourgeois, Rochelle, Bagatell, Lucas, Moreno, Andrew D J, Pearson, Steven G, DuBois
Publikováno v:
Pediatric Blood & Cancer. 70
Understanding the landscape of clinical trials for patients with neuroblastoma may inform efforts to improve drug development.We evaluated therapeutic trials for patients with neuroblastoma from 2011 to 2020 in our search using clinical trial informa
Autor:
Kevin Campbell, Pei‐Chi Kao, Arlene Naranjo, Takehiko Kamijo, Ramya Ramanujachar, Wendy B. London, Steven G. DuBois
Publikováno v:
Pediatric Blood & Cancer. 70
Outcomes for patients with INRGSS metastatic special (MS) metastatic pattern neuroblastoma at initial diagnosis are well described. Prognosis after an initial event (relapse, progression, secondary malignancy) is unclear.We investigated characteristi
Autor:
Aleksandra A. Krokhmal, Neha Kwatra, Laura Drubach, Christopher B. Weldon, Katherine A. Janeway, Steven G. DuBois, Junne Kamihara, Stephan D. Voss
Publikováno v:
Pediatric Blood & Cancer. 69
Autor:
Kieuhoa T. Vo, Steven G. DuBois, John Neuhaus, Steve E. Braunstein, Brent R. Weil, Arlene Naranjo, Sabine Irtan, Julia Balaguer, Katherine K. Matthay
Publikováno v:
PEDIATRIC BLOOD & CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
We sought to analyze biologic, clinical, and prognostic differences according to pattern of failure at the time of first relapse in neuroblastoma.Children21 years diagnosed with neuroblastoma between 1989 and 2017 with known site of first relapse (is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c7668f3288e89c10c03ee71bac9136
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15562
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15562
Autor:
Steven G. DuBois, David S. Shulman
Publikováno v:
Pediatric Drugs. 22:189-197
The neurotrophin receptor tyrosine kinase (NTRK1-3) genes have been identified as key fusion partners in a range of pediatric cancers. In childhood cancers, ETV6-NTRK3 fusions are found in the majority of infantile fibrosarcomas and congenital mesobl
Autor:
Steven G. DuBois, Rotem Fishel Ben Kenan, Steve Braunstein, Katherine K. Matthay, Daphne A. Haas-Kogan, Alexei L. Polishchuk, Randall A. Hawkins
Publikováno v:
Pediatric Blood & Cancer. 69
Objectives Patients with metaiodobenzylguanidine (MIBG)-avid relapsed or refractory neuroblastoma after initial therapy may exhibit transient responses to salvage treatment with iodine-131 metaiodobenzylguanidine (131 I-MIBG). It is unclear whether d
Autor:
Anderson B. Collier, Mark Krailo, Steven G. DuBois, Lisa Bomgaars, Mark L. Bernstein, Damon R. Reed, Ha Dang, Richard Gorlick, Katherine A. Janeway, Douglas S. Hawkins
Publikováno v:
Pediatr Blood Cancer
Seven Children’s Oncology Group phase 2 trials for patients with relapsed/progressive solid tumors were analyzed to estimate the event-free survival (EFS) for relapsed/progressive Ewing sarcoma. One hundred twenty-eight Ewing sarcoma patients were
Autor:
Alanna J. Church, Alyaa Al-Ibraheemi, Monica Hollowell, Steven G. DuBois, Franziska Wachter, Natalie B. Collins, Katherine A. Janeway, Maria Trissal
Publikováno v:
Pediatrics. 148(6)
Inflammatory myofibroblastic tumor (IMT) is a rare, mesenchymal tumor that has an increased incidence in childhood. Tumors are usually isolated to the chest, abdomen, and retroperitoneum, but metastatic presentations can be seen. Presenting symptoms